Health-care companies were flat as traders rotated back into rate-sensitive sectors in light of comments from Federal Reserve Chairman Jerome Powell.
Danish biotechnology company Genmab agreed to buy U.S. ProfoundBio for $1.8 billion in cash, seeking to expand its oncology portfolio.
UnitedHealth Group's communications moves during the recent hack of its Change Healthcare unit revealed challenges striking a balance between regulatory obligations and keeping customers informed.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
04-03-24 1748ET
